Antares Pharma, Inc., a leading developer and marketer of parenteral pharmaceuticals, has dosed its first patient in a clinical study evaluating testosterone enanthate administered weekly by ...

Antares Pharma, Inc. has reported positive results from a multi-centre phase II clinical study evaluating the pharmacokinetic profile of testosterone enanthate administered once-weekly by subcutaneous ...

Antares Pharma, Inc. has announced positive results from a multi-center phase 2 clinical study evaluating the pharmacokinetic profile of testosterone enanthate administered once-weekly by subcutaneous ...

The auto injector market represents a rapidly expanding segment within the global pharmaceutical delivery systems industry, driven by the increasing prevalence of chronic diseases and the growing ...

The auto-injectors market is forecast to reach a value of USD 5.71 billion in 2025 and is expected to expand to USD 23.31 billion by 2035, growing at a steady compound annualgrowth rate of 8.2% over ...